Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jun Xu
Observed institution:
Blood Cancer United
ORCID:
0000-0001-9285-158X
Observed ORCID:
0000-0001-9285-158X
OpenAlex ID:
A5037159583
Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
2022
·
Lee M. Greenberger
, Larry A. Saltzman
, et al.
·
Blood Cancer Discovery
·
25
Humoral and cellular immunity of two‐dose inactivated COVID‐19 vaccination in Chinese children: A prospective cohort study
2022
·
Hao Wang
, Mengze Gan
, et al.
·
Journal of Medical Virology
·
17
Dynamics of Crossed Acquired Immunity Against SARS‐CoV‐2 Variants: From Vaccine to Hybrid Immunity in China
2025
·
Hao Wang
, Zhihao Zhang
, et al.
·
Journal of Medical Virology
·
2
PDF
Supplementary Figure from Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
2023
·
Lee M. Greenberger
, Larry A. Saltzman
, et al.
·
1
Data from Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
2023
·
Lee M. Greenberger
, Larry A. Saltzman
, et al.
Data from Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
2023
·
Lee M. Greenberger
, Larry A. Saltzman
, et al.
Supplementary Figure from Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
2023
·
Lee M. Greenberger
, Larry A. Saltzman
, et al.
Feasibility and Preliminary Findings of a Novel, Patient-Centric Registry Model to Address Real-World Care Questions for Patients with Hematologic Malignancies
2022
·
Sophia C Cornew
, Anthony B Cardillo
, et al.
·
Blood
Show more works
View as search
Works count:
8
Citation count:
45
H-index:
2
I10-index:
2
Year
Topic
Type
